1. Home
  2. SNDA vs SRPT Comparison

SNDA vs SRPT Comparison

Compare SNDA & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonida Senior Living Inc.

SNDA

Sonida Senior Living Inc.

HOLD

Current Price

$41.05

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$15.58

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNDA
SRPT
Founded
1990
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.0B
IPO Year
1997
2000

Fundamental Metrics

Financial Performance
Metric
SNDA
SRPT
Price
$41.05
$15.58
Analyst Decision
Buy
Hold
Analyst Count
4
29
Target Price
$35.75
$25.85
AVG Volume (30 Days)
479.6K
3.0M
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.88
Revenue
$381,141,000.00
$2,198,237,000.00
Revenue This Year
$68.73
N/A
Revenue Next Year
$11.11
N/A
P/E Ratio
N/A
$5.35
Revenue Growth
25.24
15.58
52 Week Low
$23.78
$14.68
52 Week High
$44.39
$25.32

Technical Indicators

Market Signals
Indicator
SNDA
SRPT
Relative Strength Index (RSI) 60.15 34.07
Support Level $30.78 N/A
Resistance Level $42.79 $18.16
Average True Range (ATR) 1.62 0.88
MACD 0.07 -0.30
Stochastic Oscillator 60.44 4.46

Price Performance

Historical Comparison
SNDA
SRPT

About SNDA Sonida Senior Living Inc.

Sonida Senior Living Inc is an owner-operator of senior housing communities in the United States in terms of resident capacity. It provides senior living services to the elderly, including independent living, assisted living, Respite Care and Temporary Care Programs, Home Care Services, and memory care services. The company's objective is to provide value to residents by providing quality senior housing services at reasonable prices. The basic services offered by the company at its senior housing communities comprise meals, housekeeping, laundry, 24-hour staffing, transportation, social and recreational activities, and healthcare monitoring.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

Share on Social Networks: